These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 1943228
1. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis. Laneuville P, Sullivan AK. Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228 [Abstract] [Full Text] [Related]
3. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, Shimoda K, Takeshita M, Okamura S, Matsumoto I. Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698 [Abstract] [Full Text] [Related]
4. Different methylation patterns of the M-BCR gene in myeloblastic and lymphoblastic crisis of chronic myelocytic leukemia. Ge X, Tanaka K, Kamada N. Chin Med J (Engl); 1996 Apr; 109(4):300-3. PubMed ID: 8758292 [Abstract] [Full Text] [Related]
6. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML. Mills KI, Sproul AM, Burnett AK. Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349 [Abstract] [Full Text] [Related]
7. [Philadelphia chromosome positive acute mixed lineage leukemia with bcr (M-BCR-1) rearrangement]. Okada S, Shimizu T, Harada H, Miyoshi Y, Takizawa Y, Hagiwara S, Mori H, Niikura H, Terada H, Fujita K. Rinsho Ketsueki; 1990 Jan; 31(1):89-94. PubMed ID: 2156095 [Abstract] [Full Text] [Related]
11. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH. Kim YR, Cho HI, Yoon SS, Park S, Kim BK, Lee YK, Chun H, Kim HC, Lee DS. Genes Chromosomes Cancer; 2005 May; 43(1):37-44. PubMed ID: 15723338 [Abstract] [Full Text] [Related]
13. Chronic myeloid leukaemia lymphoid blast crisis. Relevance of molecular analysis at the bcr and immunoglobulin heavy chain gene level in monitoring response to therapy and residual disease. Lo Coco F, Diverio D, Frontani M, Wang YZ, Montefusco E, De Fabritiis P, Arcese W, De Rossi G, Mandelli F. Eur J Haematol; 1991 Mar; 46(3):172-6. PubMed ID: 1901272 [Abstract] [Full Text] [Related]
15. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator. Mills KI, Hynds SA, Burnett AK, MacKenzie ED, Birnie GD. Leukemia; 1989 Dec; 3(12):837-40. PubMed ID: 2685475 [Abstract] [Full Text] [Related]
19. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. González FA, Villegas A, Ferro MT, San Román C, Sáez I, López M, del Potro E, Alvarez A, Martínez R, Díaz Madiavilla J. Med Clin (Barc); 1993 Oct 30; 101(14):521-4. PubMed ID: 8231395 [Abstract] [Full Text] [Related]
20. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis. Fujie H, Tsuchiya S, Morita S, Itano M, Yambe T, Ohasi Y, Minegishi N, Minegishi M, Satou T, Konno T. Leukemia; 1994 Sep 30; 8(9):1592-5. PubMed ID: 8090037 [Abstract] [Full Text] [Related] Page: [Next] [New Search]